// App-Quantinova.ai

6334 : In vivo efficacy and toxicity of a reduced potency DNA guanine mono-alkylating ADC payload suitable for the treatment of solid tumors

Researchers

Presenter

  • Paul J. M. Jackson

Principal Investigators

  • Paolo Andriollo

  • Nicolas Veillard

  • George Procopiou

  • David E. Thurston

Medical Centers

  • Femtogenix Ltd, Harpenden, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Musculoskeletal

Disease

  • Solid malignancies

  • Osteosarcoma

Biomarkers

  • Cartilage oligomeric matrix protein

  • Immunoglobulin G

  • Apparent diffusion coefficient

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved